A prospective, multicentre, open, non-interventional study to evaluate the risk-benefit assessment in the updosing phase of a house dust mite specific subcutaneous immunotherapy

A prospective, multicentre, open, non-interventional study to evaluate the risk-benefit assessment in the updosing phase of a house dust mite specific subcutaneous immunotherapy

Mösges R., Allekotte S., Zieglmayer P., Weissenbaeck S., Moser M., Akicel C., Meyer M., Kramer M.F., Guethoff S., Birkholz K.
EAACI, Lisbon, 2019